BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 18429947)

  • 1. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
    Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of insulin resistance in young adult survivors of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma.
    Beauloye V; Steffens M; Zech F; Vermylen C; Maiter D
    Clin Endocrinol (Oxf); 2013 May; 78(5):790-8. PubMed ID: 22967316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Berger C; Le-Gallo B; Donadieu J; Richard O; Devergie A; Galambrun C; Bordigoni P; Vilmer E; Plouvier E; Perel Y; Michel G; Stephan JL
    Bone Marrow Transplant; 2005 May; 35(10):991-5. PubMed ID: 15806126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation.
    Jarfelt M; Bjarnason R; Lannering B
    Pediatr Blood Cancer; 2004 Jun; 42(7):582-8. PubMed ID: 15127412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.
    Link K; Moëll C; Osterberg K; Persson R; Ørbaek P; Garwicz S; Cavallin-Ståhl E; Erfurth EM
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):617-25. PubMed ID: 17054463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia.
    Frisk P; Arvidson J; Gustafsson J; Lönnerholm G
    Bone Marrow Transplant; 2004 Jan; 33(2):205-10. PubMed ID: 14628079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma.
    Nysom K; Holm K; Michaelsen KF; Hertz H; Jacobsen N; Müller J; Mølgaard C
    Bone Marrow Transplant; 2000 Jan; 25(2):191-6. PubMed ID: 10673679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
    van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
    Haddy TB; Mosher RB; Nunez SB; Reaman GH
    Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation.
    Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A
    Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence.
    Shalitin S; Phillip M; Stein J; Goshen Y; Carmi D; Yaniv I
    Bone Marrow Transplant; 2006 Jun; 37(12):1109-17. PubMed ID: 16699534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone deficiency after childhood bone marrow transplantation with total body irradiation: interaction with adiposity and age.
    Davis NL; Stewart CE; Moss AD; Woltersdorf WW; Hunt LP; Elson RA; Cornish JM; Stevens MC; Crowne EC
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):508-17. PubMed ID: 25807881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
    Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
    Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
    Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
    Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
    Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
    Darzy KH; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.
    Perkins JL; Kunin-Batson AS; Youngren NM; Ness KK; Ulrich KJ; Hansen MJ; Petryk A; Steinberger J; Anderson FS; Baker KS
    Pediatr Blood Cancer; 2007 Dec; 49(7):958-63. PubMed ID: 17474113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease.
    Trimis G; Moschovi M; Papassotiriou I; Chrousos G; Tzortzatou-Stathopoulou F
    J Pediatr Hematol Oncol; 2007 May; 29(5):309-14. PubMed ID: 17483708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.